Press Releases

All News
By Year:
2019
2018
2017
2016

Oct 14, 2019

DiaMedica Therapeutics Announces Clearance to Initiate Phase II Clinical Trial of DM199 for Chronic Kidney Disease

Sep 6, 2019

DiaMedica Therapeutics to Present at Lake Street’s 3rd Annual Best Ideas Growth (BIG3) Conference on September 12, 2019

Sep 3, 2019

DiaMedica Therapeutics to Present at the 2019 Dougherty & Co. Institutional Investor Conference

Aug 13, 2019

DiaMedica Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update

Aug 12, 2019

DiaMedica Therapeutics to Present at the 2019 Intellisight Investor Conference on August 14, 2019

Aug 8, 2019

DiaMedica Therapeutics to Report Second Quarter 2019 Financials and Provide a Business Update August 13, 2019

Jun 19, 2019

DiaMedica Therapeutics Announces Interim Results from Phase 1b Trial of DM199 in Chronic Kidney Disease Participants

May 22, 2019

DiaMedica Therapeutics to Present at the 16th Annual Craig-Hallum Institutional Investor Conference on May 29, 2019

May 21, 2019

DiaMedica Therapeutics Announces Formation of Scientific Advisory Board for Kidney Disease

May 13, 2019

DiaMedica Therapeutics Announces First Quarter 2019 Financial Results and Provides Business Update